Guy Pratt

10.1k total citations
184 papers, 5.3k citations indexed

About

Guy Pratt is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Guy Pratt has authored 184 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Hematology, 80 papers in Genetics and 75 papers in Molecular Biology. Recurrent topics in Guy Pratt's work include Multiple Myeloma Research and Treatments (76 papers), Chronic Lymphocytic Leukemia Research (69 papers) and Lymphoma Diagnosis and Treatment (30 papers). Guy Pratt is often cited by papers focused on Multiple Myeloma Research and Treatments (76 papers), Chronic Lymphocytic Leukemia Research (69 papers) and Lymphoma Diagnosis and Treatment (30 papers). Guy Pratt collaborates with scholars based in United Kingdom, United States and Spain. Guy Pratt's co-authors include Paul Moss, Chris Fegan, Chris Pepper, Oliver Goodyear, Gareth J. Morgan, Tatjana Stanković, Jane Starczynski, Roger G. Owen, Mark T. Drayson and Thet Thet Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Guy Pratt

171 papers receiving 5.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Guy Pratt 2.4k 1.9k 1.8k 1.5k 1.2k 184 5.3k
Ulrich Jäger 1.8k 0.8× 2.4k 1.2× 1.7k 0.9× 1.2k 0.8× 1.2k 0.9× 172 5.7k
William Blum 2.5k 1.1× 2.7k 1.4× 1.3k 0.7× 1.1k 0.7× 1.0k 0.8× 188 5.6k
Giuseppe Visani 2.2k 0.9× 4.0k 2.1× 1.4k 0.8× 2.0k 1.3× 930 0.8× 285 6.6k
Vinod Pullarkat 1.9k 0.8× 3.8k 2.0× 1.2k 0.7× 1.4k 0.9× 865 0.7× 228 6.0k
Lubomir Sokol 1.3k 0.5× 1.3k 0.7× 1.8k 1.0× 1.4k 0.9× 1.4k 1.1× 269 5.3k
Mark Heaney 2.1k 0.9× 1.0k 0.5× 962 0.5× 906 0.6× 695 0.6× 91 4.5k
François Dreyfus 3.0k 1.3× 4.0k 2.0× 1.0k 0.6× 1.6k 1.1× 721 0.6× 126 6.2k
Robert Vescio 3.0k 1.3× 2.9k 1.5× 3.0k 1.7× 591 0.4× 878 0.7× 150 6.0k
Sung‐Soo Yoon 1.6k 0.7× 1.8k 0.9× 1.5k 0.8× 637 0.4× 630 0.5× 342 4.2k
Hans Erik Johnsen 2.1k 0.9× 2.6k 1.3× 2.3k 1.3× 1.2k 0.8× 2.1k 1.7× 261 7.1k

Countries citing papers authored by Guy Pratt

Since Specialization
Citations

This map shows the geographic impact of Guy Pratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Pratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Pratt more than expected).

Fields of papers citing papers by Guy Pratt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Pratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Pratt. The network helps show where Guy Pratt may publish in the future.

Co-authorship network of co-authors of Guy Pratt

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Pratt. A scholar is included among the top collaborators of Guy Pratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Pratt. Guy Pratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinney, Jennifer H., Candice Roufosse, Aristeidis Chaidos, et al.. (2025). Diagnosis and management of monoclonal gammopathy of renal significance: A British Society for Haematology good practice paper. British Journal of Haematology. 206(2). 447–463.
2.
Drayson, Mark T., Dina Patel, Guy Pratt, et al.. (2024). Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services. British Journal of Haematology. 204(2). 476–486. 1 indexed citations
3.
Yong, Kwee, Karthik Ramasamy, Simon Stern, et al.. (2024). Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British Journal of Haematology. 204(4). 1193–1206. 1 indexed citations
4.
Kothari, Jaimal, Toby A. Eyre, Ali Rismani, et al.. (2024). PembroWM : A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia. British Journal of Haematology. 205(6). 2273–2281. 3 indexed citations
5.
6.
Goh, Vicky, et al.. (2024). National myeloma patient survey shows continuing inappropriate imaging and geographical inequalities. British Journal of Radiology. 97(1160). 1443–1449. 2 indexed citations
7.
8.
Kaiser, Martin, Andrew Hall, Katrina Walker, et al.. (2023). Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma. Journal of Clinical Oncology. 41(23). 3945–3955. 54 indexed citations
9.
Pratt, Guy, Jennifer H. Pinney, & Paul Cockwell. (2023). How I Treat Light Chain Cast Nephropathy. Clinical Journal of the American Society of Nephrology. 19(5). 650–652.
10.
McIlroy, Graham, Sylvia Feyler, Rakesh Popat, et al.. (2023). Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic. Blood Cancer Journal. 13(1). 38–38. 8 indexed citations
11.
12.
Pratt, Guy, et al.. (2023). Renal Disorders Associated with Waldenström Macroglobulinaemia, IgM MGUS and IgM-Producing B-Cell Lymphoproliferative Disorders. SHILAP Revista de lepidopterología. 4(2). 184–195. 1 indexed citations
13.
Parry, Helen, Alexander C. Dowell, Jianmin Zuo, et al.. (2021). PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicity. PLoS Pathogens. 17(3). e1009349–e1009349. 18 indexed citations
14.
Parry, Helen, Graham McIlroy, Rachel Bruton, et al.. (2021). Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia. Blood Cancer Journal. 11(7). 136–136. 74 indexed citations
15.
16.
Heaney, Jennifer, Gulnaz Iqbal, Janet Dunn, et al.. (2020). Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study. SHILAP Revista de lepidopterología. 7(10). 1–70. 2 indexed citations
17.
Atkin, Catherine, Gulnaz Iqbal, Tim Planche, et al.. (2020). Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial. British Journal of Haematology. 192(6). 997–1005. 5 indexed citations
18.
Sherborne, Amy L., Vallari Shah, Sidra Ellis, et al.. (2017). Improving Outcomes for Patients with High-Risk Myeloma Via Prospective Trial Evidence: The Myeloma UK Nine Optimum Trial. Blood. 130. 1767–1767. 2 indexed citations
19.
Kwok, Marwan, Nicholas Davies, Angelo Agathanggelou, et al.. (2015). ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells. Blood. 127(5). 582–595. 211 indexed citations
20.
Pratt, Guy, et al.. (1977). The telephone: an overlooked technology for prevention in family medicine.. PubMed. 46(1). 176–469. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrich Jäger Breakdown of academic impact, for papers by William Blum Breakdown of academic impact, for papers by Giuseppe Visani Breakdown of academic impact, for papers by Vinod Pullarkat Breakdown of academic impact, for papers by Lubomir Sokol Breakdown of academic impact, for papers by Mark Heaney Breakdown of academic impact, for papers by François Dreyfus Breakdown of academic impact, for papers by Robert Vescio Breakdown of academic impact, for papers by Sung‐Soo Yoon Breakdown of academic impact, for papers by Hans Erik Johnsen
Rankless by CCL
2026